Mitochondrial mitophagy protection combining rivaroxaban and aspirin in high glucose-exposed human coronary artery endothelial cell. An in vitro study

PURPOSE: Combination of Rivaroxaban plus Aspirin improved cardiovascular outcome in patients with stable cardiovascular disease. The aim was to determine if Rivaroxaban and acetylsalicylic acid alone or in combination may protect mitochondrial mitophagy in human coronary artery endothelial cells (HC...

Descripción completa

Detalles Bibliográficos
Autores principales: Zekri-Nechar, Khaoula, Zamorano-León, José Javier, Cortina-Gredilla, Mercedes, López-de-Andrés, Ana, Jiménez-García, Rodrigo, Navarro-Cuellar, Carlos, López-Farré, Antonio, Martínez-Martínez, Carlos Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578168/
https://www.ncbi.nlm.nih.gov/pubmed/36250331
http://dx.doi.org/10.1177/14791641221129877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578168/
https://www.ncbi.nlm.nih.gov/pubmed/36250331
http://dx.doi.org/10.1177/14791641221129877

Ejemplares similares